ADO 0.00% 2.1¢ anteotech ltd

Ann: Life Science Update, page-52

  1. 1,787 Posts.
    lightbulb Created with Sketch. 417
    If nothing has changed there wouldn’t be an announcement!
    The Indian update does ‘seem’ a little different as they’re testing symptomatic people with both nasal and saliva swabs, to me that’s a huge positive as it may bring the saliva test to market quicker if accuracy is verified against nasal swabs.
    If regulatory approval does take a month longer due to forces beyond ADO’s control; I can wait.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $51.83M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $4.943K 227.7K

Buyers (Bids)

No. Vol. Price($)
3 310468 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 428309 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.